White Paper: Validation of Solid Phase Cytometry for Rapid Sterility Testing
Improving Sterility Testing Through Rapid Microbiological Methods
Sterility testing remains one of the most time-critical and risk-sensitive steps in the release of sterile and compounded drug products. Traditional culture-based methods under USP <71> are well established but require extended incubation periods, which can be challenging for products with short shelf lives.
This previously published white paper, authored by Anthony T. Grilli, MS, explores the validation of solid phase cytometry as a rapid alternative method for sterility testing, using Scan RDI technology to detect viable microorganisms more quickly while maintaining scientific and regulatory rigour. The paper outlines laboratory qualification and validation work carried out by Cormica Focus Laboratories and discusses how rapid microbiological methods can support timely, confident sterility confirmation.
Why This Research Matters:
Adoption of rapid microbiological methods within pharmaceutical sterility testing has historically required careful justification to demonstrate equivalence to compendial approaches. Robust validation, clear understanding of detection principles, and alignment with regulatory expectations remain critical for successful implementation.
The scientific principles discussed in this paper continue to inform how manufacturers and compounders evaluate sterility testing strategies today. As product lifecycles shorten and pressure to reduce time to release increases, understanding alternative approaches alongside traditional USP <71> testing is increasingly valuable.
Cormica’s Expertise in Sterility and Rapid Microbiology Testing
Cormica supports pharmaceutical, medical device, and combination product manufacturers with accredited sterility testing, rapid microbiological methods, and broader microbiology services across its global laboratory network in the US, UK, and EU.
Our global laboratory network provides manufacturers with high-quality, GMP– and ISO 17025-aligned testing to accelerate product development, regulatory submissions, and ongoing compliance.
Authors:
Walter Zwisler, MS
Tony holds an MSc in Microbiology from Rutgers University and has over 30 years of experience in industrial microbiology. He is General Manager of Cormica Focus Laboratories and an active member of PDA, ASTM, and CETA.
Download:
We will email you the link to the PDF file.
Related resources
Cormica's Webinars
Recent News
Technical Resources
Laboratories near you, supporting global product success
With accredited laboratories in the UK, EU and US, we support pharmaceutical, medical device and combination product manufacturers worldwide. Local support combined with global quality, delivered by teams who understand your regulatory requirements.
Our Clients’ Experiences